Introduction

Valkyrie Pharmaceutical Testosterone C250 is presented in a 10-milliliter multidose vial, labeled to contain 250 milligrams of testosterone cypionate per milliliter. To support its commitment to harm reduction, AnabolicLab procured samples of this product from a European-based internet source for independent verification. The samples were purchased between January 1, 2018, and February 28, 2018, and submitted to SIMEC AG, a globally recognized analytical laboratory, for comprehensive testing.

The analysis, fully funded by AnabolicLab, included HPLC-UV quantitative dosage testing and microbiological contamination assessments. The testing revealed that the product exceeded its label claim, showcasing a higher-than-expected concentration of the active ingredient. By publishing these findings, AnabolicLab emphasizes transparency and accountability in the anabolic steroid market. This report is intended solely for harm reduction purposes, helping consumers make informed decisions.

Testing Results and Authentication

The samples were received by SIMEC AG on February 28, 2018, and the report was finalized on March 27, 2018. The product was identified using the batch number HGM2366 and was verified with an expiration date of November 2019.

Product Overview

• Manufacturer: Valkyrie Pharmaceutical
• Product Name: Testosterone C250
• Active Ingredient: Testosterone Cypionate
• Batch Number: HGM2366
• Expiration Date: November 2019
• Delivery Method: Injectable (10-milliliter multidose vial)
• Specification: 250 mg/ml testosterone cypionate

Sample Acquisition and Testing

• Date Purchased: Between January 1, 2018, and February 28, 2018
• Source: European-based internet supplier
• Product Submitted By: AnabolicLab
• Analysis Paid For By: AnabolicLab
• Analysis Performed By: SIMEC AG
• Date Received by Lab: February 28, 2018
• Date Report Completed: March 27, 2018

Testing Results

Quantitative Dosage Testing (HPLC-UV):

• Claimed Dosage: 250 mg/ml testosterone cypionate
• Measured Dosage: 269 mg/ml testosterone cypionate
• Accuracy: 107.6% (exceeding the label claim)
• Variance: +7.6% (measured dosage exceeded label claim by 7.6%)

Microbiological Contamination Testing:

• Total Aerobial Microbiological Count (TAMC): No contamination detected
• Total Yeast and Mold Count (TYMC): No contamination detected

Summary

The independent analysis of Valkyrie Pharmaceutical Testosterone C250 revealed that the product contained 269 mg/ml testosterone cypionate, exceeding the label claim by 7.6%. The findings confirm the product’s authenticity and highlight its consistency with the stated quality standards. No microbiological contamination was detected, ensuring the product’s safety for use. By sharing this information, AnabolicLab underscores the importance of transparency and harm reduction in the anabolic steroid market.

Commitment to Harm Reduction

AnabolicLab remains dedicated to harm reduction by independently analyzing and publishing results that empower consumers to verify product quality. This approach mitigates the risks associated with mislabeled or contaminated substances while promoting transparency and accountability in the anabolic steroid market.

Disclaimer
The information provided here is for educational and harm reduction purposes only. AnabolicLab does not endorse or promote the use of anabolic steroids or other controlled substances.

Discuss the Valkyrie Pharmaceutical Testosterone C250 lab test results on the AnabolicLab Forum.

(The following images are photographs of the actual product that was submitted for testing.)

Valkyrie Pharmaceutical Testosterone C250 Dosage Quantification Lab Results [PDF]
Does Valkyrie Pharmaceutical Testosterone C250 really contain 250 milligrams of testosterone cypionate in each milliliter of solution? Is the product free of microbiological contamination? HPLC-UV, TAMC,…

Size	192.14 KB
Downloaded	408 times
Last Updated	November 28, 2018
Download

---